Saturna Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Saturna Capital’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,512	Closed	-$780K	–	371
2015 Q1	$780K	Sell	4,512 -3,691	-45%	-$542K	0.02%	140
2014 Q4	$943K	Buy	8,203 +1,466	+22%	+$178K	0.02%	138
2014 Q3	$1.05M	Sell	6,737 -1,555	-19%	-$225K	0.03%	141
2014 Q2	$1.02M	Hold	8,292	–	–	0.03%	138
2014 Q1	$859K	Hold	8,292	–	–	0.02%	142
2013 Q4	$746K	Hold	8,292	–	–	0.02%	159
2013 Q3	$555K	Buy	+8,292	New	+$571K	0.01%	184

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Saturna Capital's SLXP Position: Q2 2015 in Review

Saturna Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 4,512 shares — an estimated $780K sold.

Saturna Capital first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $1.05M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Saturna Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Saturna Capital sold 4,512 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $780K.
Saturna Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
Saturna Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.05M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Saturna Capital's 13F filing for Q2 2015, filed 13 Aug 2015.